menu

HDV

Podcasts

Beyond the Mic: Exploring the Journeys of Leaders.

Cholestatic Pruritus Across the Age Spectrum: What Are You Missing?

When considering cholestatic pruritus across the age spectrum, a key point to remember is that while the underlying mechanism is similar, pediatric patients often present with unique challenges in diagnosis and management due to factors like limited communication abilities, potential side effects of medications, and the need for careful dosage adjustments; additionally, older adults might have co-morbidities that complicate treatment and require a more nuanced approach to managing pruritus

Webcasts

cardImg

Recognizing Hepatitis D (HDV): Epidemiology, Virology, Tests and Treatment Options

Robert Gish, MD & Tatyana Kushner, MD, MSCE

This program is supported by an educational grant from Gilead Sciences, Inc.

2025
cardImg

HBV, HCV, and HDV

Vinod Rustgi, MD, MBA & Nikolaos Pyrsopoulos, MD

2025
cardImg

HBV/HDV Hot Topics & Virtual Roundtable

Dr. Robert Wong & Expert Panelists

2025
View All Webcasts arrow

Publications

View All Modules arrow
pcbimg

Diagnosis and Management of Hepatitis Delta Virus Infection

Hepatitis D virus (HDV) depends on hepatitis B virus (HBV) to enter and exit hepatocytes and to replicate. Despite this dependency, HDV can cause severe liver disease. HDV accelerates liver fibrosis, increases the risk of hepatocellular carcinoma, and hastens hepatic decompensation compared to chronic HBV monoinfection. The Chronic Liver Disease Foundation (CLDF) formed an expert panel to publish updated guidelines on the testing, diagnosis, and management of hepatitis delta virus. The panel group performed network data review on the transmission, epidemiology, natural history, and disease sequelae of acute and chronic HDV infection. Based on current available evidence, we provide recommendations for screening, testing, diagnosis, and treatment of hepatitis D infection and review upcoming novel agents that may expand treatment options. The CLDF recommends universal HDV screening for all patients who are Hepatitis B surface antigen-positive. Initial screening should be with an assay to detect antibodies generated against HDV (anti-HDV). Patients who are positive for anti-HDV IgG antibodies should then undergo quantitative HDV RNA testing. We also provide an algorithm that describes CLDF recommendations on the screening, diagnosis, testing, and initial management of Hepatitis D infection.

Abstract Library

Unlocking Boundless Knowledge Through Abstracts

View All Modules arrow
alcbimg

Prevalence and Spectrum of Chronic Liver Disease Among Patients Seeking Health Care in Ghana.

Lehmann Felix (F);Killer Alexander (A);Wels Sarah (S);Schmiedel Stefan (S);Phillips Richard Odame (RO);Roppert Pia Luise (PL);Eberhardt Kirsten Alexandra (KA);Holtfreter Martha Charlotte (MC);Stauga Sabine (S);Lohse Ansgar Wilhelm (AW);Ehrhardt Stephan (S);Opare-Sem Ohene (O);Orth Hans Martin (HM);Sarfo Fred Stephen (FS);Drosten Christian (C);Eis-Hübinger Anna Maria (AM);Luedde Tom (T);Glebe Dieter (D);Drexler Jan Felix (JF);Feldt Torsten (T)

alcbimg

Unveiling DNAJB12 and DNAJB14 as crucial chaperones in hepatitis B and D virus particle morphogenesis.

Angelo Léna (L);Boulon Richard (R);Labonté Patrick (P)

alcbimg

Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020.

Furquim d'Almeida Arno (A);Ho Erwin (E);Schüttler Christian (C);Beutels Philippe (P);Hens Niel (N);Dudareva Sandra (S);Van Damme Pierre (P);Theeten Heidi (H);Vanwolleghem Thomas (T)